Clinical Trial Update: High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus [Phase 3]

View source ↗

Summary

Phase 3 trial of high-dose fluconazole for cutaneous leishmaniasis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Fluconazole (Fluconazole)

Snippet

Sponsor: Hospital Universitário Professor Edgard Santos | Conditions: Cutaneous Leishmaniasis | Phase 3 | Status: TERMINATED